Skip to main content

Valsartan, Losartan and Irbesartan Use in the USA, UK, Canada and Denmark After the Nitrosamine Recalls: A Descriptive Cohort Study

    Basic Details
    Date
    Type
    Publication
    Description

    We sought to examine valsartan, losartan and irbesartan usage and switching patterns in the United States of America, United Kingdom, Canada and Denmark before and after July 2018, when the first Angiotensin-Receptor-Blocker (ARB) (valsartan) was recalled. This retrospective cohort study included patients aged 18 years and older.

    Author(s)

    Efe Eworuke, Mayura Shinde, Laura Hou, Michael J Paterson, Peter BjĂždstrup Jensen, Judith C Maro, Ashish Rai, Daniel Scarnecchia, Dinci Pennap, Daniel Woronow, Rebecca E Ghosh, Stephen Welburn, Anton Pottegard, Robert W Platt, Hana Lee, Marie C Bradley

    Corresponding Author

    Efe Eworuke; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD.

    Email: efeeworuke@gmail.com